Skip to content

GeneDx Holdings WGS Current Debt

Current Debt at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$80.31M0.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
$503M+50,200%
Revvity logo
RevvityRVTY
$575.83M+237,847%
Labcorp Holdings logo
Labcorp HoldingsLH
$500.4M+10,325%
Agilent Technologies logo
Agilent TechnologiesA
$304M+108%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.72B-24.3%
Enterprise value$1.73B-22.8%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's current debt?
GeneDx Holdings (WGS) reported current debt of $0 in Q1 2026.
How has GeneDx Holdings's current debt changed year-over-year?
GeneDx Holdings's current debt decreased by 100.0% year-over-year, from $1.22M to $0.
What is the long-term trend for GeneDx Holdings's current debt?
Over 5 years (2020 to 2025), GeneDx Holdings's current debt has grown at a 20.7% compound annual growth rate (CAGR), from $1.77M to $4.54M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.